Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class (Glycopeptides and Lipoglycopeptides, Oxazolidinones, Lipopeptides, Cephalosporin, Tetracycline, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00019312 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Methicillin-resistant staphylococcus aureus (MRSA) is an infection caused by antibiotic-resistant strains of the pathogen Staphylococcus aureus. The disease causes skin and tissue infection and is transmitted by direct skin-to-skin contact. This infection is mainly associated with invasive procedures such as surgeries or intravenous tubing. MRSA drugs are used to kill or restrain Methicillin-resistant staphylococcus aureus infection.

MARKET DYNAMICS

The growing incidence of infections associated with Methicillin-resistant staphylococcus aureus (MRSA) pathogens and the rising number of pipeline products for MRSA drugs are significant factors expected to boost the growth of the global Methicillin-resistant staphylococcus aureus (MRSA) drugs. However, the introduction of low-cost generic drugs can hamper the market growth.

MARKET SCOPE

The "Methicillin-Resistant Staphylococcus Aureus Drugs Market Analysis to 2027" is a specialized and in-depth study of the Pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of methicillin-resistant staphylococcus aureus drugs market with detailed market segmentation with type and end user. The methicillin-resistant staphylococcus aureus drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in methicillin-resistant staphylococcus aureus drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The methicillin-resistant staphylococcus aureus drugs market is segmented on the basis of drug class and distribution channel. On the basis of drug class, the methicillin-resistant staphylococcus aureus drugs market is divided into glycopeptides and lipoglycopeptides, oxazolidinones, lipopeptides, cephalosporin, tetracycline and others. Based on distribution channel, methicillin-resistant staphylococcus aureus drugs market can be segmented as hospital pharmacies, retail pharmacies and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the methicillin-resistant staphylococcus aureus drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. methicillin-resistant staphylococcus aureus drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyses factors affecting methicillin-resistant staphylococcus aureus drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting methicillin-resistant staphylococcus aureus drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in methicillin-resistant staphylococcus aureus drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players methicillin-resistant staphylococcus aureus drugs market is anticipated to have lucrative growth opportunities in the future with the rising demand for methicillin-resistant staphylococcus aureus drugs in the global market. Below mentioned is the list of few companies engaged in the methicillin-resistant staphylococcus aureus drugs market.

The report also includes the profiles of key players in methicillin-resistant staphylococcus aureus drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Merck and Co., Inc.
  •  Pfizer Inc.
  •  Teva Pharmaceutical Industries Ltd.
  •  AbbVie Inc.
  •  Basilea Pharmaceutica Ltd.
  •  Allergan plc
  •  Theravance Biopharma
  •  Melinta Therapeutics, Inc.
  •  Novartis AG
  •  Cumberland Pharmaceuticals Inc

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Methicillin-Resistant Staphylococcus Aureus Drugs Market - By Drug Class
1.3.2 Methicillin-Resistant Staphylococcus Aureus Drugs Market - By Distribution Channel
1.3.3 Methicillin-Resistant Staphylococcus Aureus Drugs Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS - GLOBAL MARKET OVERVIEW
6.2. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. GLYCOPEPTIDES AND LIPOGLYCOPEPTIDES
7.3.1. Overview
7.3.2. Glycopeptides and Lipoglycopeptides Market Forecast and Analysis
7.4. OXAZOLIDINONES
7.4.1. Overview
7.4.2. Oxazolidinones Market Forecast and Analysis
7.5. LIPOPEPTIDES
7.5.1. Overview
7.5.2. Lipopeptides Market Forecast and Analysis
7.6. CEPHALOSPORIN
7.6.1. Overview
7.6.2. Cephalosporin Market Forecast and Analysis
7.7. TETRACYCLINE
7.7.1. Overview
7.7.2. Tetracycline Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis

9. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Methicillin-Resistant Staphylococcus Aureus Drugs Market Overview
9.1.2 North America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis
9.1.3 North America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Drug Class
9.1.4 North America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.1.5.1.1 United States Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.1.5.1.2 United States Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.1.5.2 Canada Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.1.5.2.1 Canada Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.1.5.2.2 Canada Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.1.5.3 Mexico Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.1.5.3.1 Mexico Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.1.5.3.2 Mexico Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market Overview
9.2.2 Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis
9.2.3 Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.2.5.1.1 Germany Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.2.5.1.2 Germany Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.2.5.2 France Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.2.5.2.1 France Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.2.5.2.2 France Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.2.5.3 Italy Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.2.5.3.1 Italy Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.2.5.3.2 Italy Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.2.5.4 Spain Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.2.5.4.1 Spain Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.2.5.4.2 Spain Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.2.5.5 United Kingdom Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.2.5.5.1 United Kingdom Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.2.5.5.2 United Kingdom Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.2.5.6 Rest of Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.2.5.6.1 Rest of Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.2.5.6.2 Rest of Europe Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market Overview
9.3.2 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.3.5.1.1 Australia Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.3.5.1.2 Australia Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.3.5.2 China Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.3.5.2.1 China Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.3.5.2.2 China Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.3.5.3 India Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.3.5.3.1 India Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.3.5.3.2 India Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.3.5.4 Japan Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.3.5.4.1 Japan Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.3.5.4.2 Japan Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.3.5.5 South Korea Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.3.5.5.1 South Korea Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.3.5.5.2 South Korea Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.3.5.6.2 Rest of Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market Overview
9.4.2 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.4.5.1.1 South Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.4.5.1.2 South Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.4.5.2 Saudi Arabia Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.4.5.2.1 Saudi Arabia Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.4.5.2.2 Saudi Arabia Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.4.5.3 U.A.E Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.4.5.3.1 U.A.E Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.4.5.3.2 U.A.E Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.4.5.4.2 Rest of Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market Overview
9.5.2 South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis
9.5.3 South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.5.5.1.1 Brazil Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.5.5.1.2 Brazil Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.5.5.2 Argentina Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.5.5.2.1 Argentina Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.5.5.2.2 Argentina Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel
9.5.5.3 Rest of South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market
9.5.5.3.1 Rest of South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market by Drug Class
9.5.5.3.2 Rest of South and Central America Methicillin-Resistant Staphylococcus Aureus Drugs Market by Distribution Channel

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS DRUGS MARKET, KEY COMPANY PROFILES
11.1. MERCK AND CO., INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. PFIZER INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ABBVIE INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BASILEA PHARMACEUTICA LTD.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ALLERGAN PLC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. THERAVANCE BIOPHARMA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MELINTA THERAPEUTICS, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. NOVARTIS AG
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CUMBERLAND PHARMACEUTICALS INC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1.Merck and Co., Inc.
2.Pfizer Inc.
3.Teva Pharmaceutical Industries Ltd.
4.AbbVie Inc.
5.Basilea Pharmaceutica Ltd.
6.Allergan plc
7.Theravance Biopharma
8.Melinta Therapeutics, Inc.
9.Novartis AG
10.Cumberland Pharmaceuticals Inc
TIPRE00019312
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking